These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial. Högl B, Saletu M, Brandauer E, Glatzl S, Frauscher B, Seppi K, Ulmer H, Wenning G, Poewe W. Sleep; 2002 Dec 15; 25(8):905-9. PubMed ID: 12489899 [Abstract] [Full Text] [Related]
11. Effects of modafinil on cognitive and meta-cognitive performance. Baranski JV, Pigeau R, Dinich P, Jacobs I. Hum Psychopharmacol; 2004 Jul 15; 19(5):323-32. PubMed ID: 15252824 [Abstract] [Full Text] [Related]
12. The efficacy and safety of armodafinil as treatment for adults with excessive sleepiness associated with narcolepsy. Harsh JR, Hayduk R, Rosenberg R, Wesnes KA, Walsh JK, Arora S, Niebler GE, Roth T. Curr Med Res Opin; 2006 Apr 15; 22(4):761-74. PubMed ID: 16684437 [Abstract] [Full Text] [Related]
16. Modafinil for the treatment of hypersomnia associated with myotonic muscular dystrophy in adults: a multicenter, prospective, randomized, double-blind, placebo-controlled, 4-week trial. Orlikowski D, Chevret S, Quera-Salva MA, Laforêt P, Lofaso F, Verschueren A, Pouget J, Eymard B, Annane D. Clin Ther; 2009 Aug 15; 31(8):1765-73. PubMed ID: 19808135 [Abstract] [Full Text] [Related]
17. Effects of the novel neuroprotective agent, riluzole, on human brain function and behavior: I. Double-blind, placebo-controlled EEG mapping and psychometric studies under normoxia. Saletu B, Grünberger J, Anderer P, Linzmayer L. Methods Find Exp Clin Pharmacol; 1996 Aug 15; 18(1):55-66. PubMed ID: 8721257 [Abstract] [Full Text] [Related]